US Stock MarketDetailed Quotes

OBIO Orchestra BioMed

Watchlist
  • 5.790
  • +0.410+7.62%
Close Jan 3 16:00 ET
  • 5.600
  • -0.190-3.28%
Post 20:01 ET
220.10MMarket Cap-3.81P/E (TTM)

Orchestra BioMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
135.56%987K
-14.97%778K
-46.74%620K
-21.88%2.76M
-76.25%262K
-63.97%419K
128.18%915K
34.41%1.16M
551.79%3.53M
1.1M
Operating revenue
135.56%987K
-14.97%778K
-46.74%620K
-21.88%2.76M
-76.25%262K
-63.97%419K
128.18%915K
34.41%1.16M
551.79%3.53M
--1.1M
Cost of revenue
65.85%68K
-18.52%44K
-22.73%34K
-11.85%186K
-11.32%47K
-26.79%41K
-10.00%54K
4.76%44K
6.03%211K
53K
Gross profit
143.12%919K
-14.75%734K
-47.68%586K
-22.52%2.57M
-79.52%215K
-65.85%378K
152.49%861K
35.92%1.12M
438.63%3.32M
1.05M
Operating expense
15.83%17.26M
27.33%17.59M
18.51%15.01M
50.31%54.08M
16.71%12.7M
33.36%14.9M
73.25%13.82M
112.79%12.67M
72.83%35.98M
10.88M
Selling and administrative expenses
-10.69%5.67M
21.61%6.47M
33.69%5.9M
44.35%20.26M
25.49%4.19M
20.27%6.34M
80.52%5.32M
78.01%4.41M
77.02%14.03M
--3.34M
Research and development costs
35.49%11.6M
30.91%11.13M
10.39%9.11M
54.12%33.82M
12.83%8.51M
45.08%8.56M
69.00%8.5M
137.59%8.25M
70.25%21.95M
--7.54M
Operating profit
-12.52%-16.34M
-30.13%-16.86M
-24.93%-14.42M
-57.72%-51.51M
-26.99%-12.48M
-44.27%-14.52M
-69.71%-12.96M
-125.14%-11.55M
-49.81%-32.66M
-9.83M
Net non-operating interest income expense
0.11%916K
-4.14%902K
14.80%1.02M
7,598.00%3.85M
136.25%1.11M
1,352.38%915K
482.52%941K
475.00%885K
105.39%50K
469K
Non-operating interest income
0.11%916K
-4.14%902K
14.80%1.02M
7,598.00%3.85M
--1.11M
--915K
--941K
--885K
--50K
----
Other net income (expense)
25.81%-23K
80.00%-56K
-46.15%-1.46M
-269.57%-1.45M
205.40%293K
-193.94%-31K
23.29%-280K
-247.57%-1M
-391K
Gain on sale of security
----
25.81%-23K
83.93%-45K
2.19%-312K
24.81%-294K
205.40%293K
-104.34%-31K
23.29%-280K
-10.76%-319K
---391K
Special income (charges)
----
----
----
-68.77%-1.15M
----
----
----
----
---682K
--0
-Less:Other special charges
----
----
----
68.77%1.15M
----
----
----
----
--682K
--0
Other non- operating income (expenses)
----
----
---11K
----
----
----
----
----
----
----
Income before tax
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
Income tax
Net income
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
Net income continuous Operations
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
---9.75M
Minority interest income
Net income attributable to the parent company
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
Basic earnings per share
-7.89%-0.41
-28.57%-0.45
5.00%-0.38
-39.22%-1.48
-19.97%-0.37
-16.84%-0.38
-41.01%-0.35
-120.73%-0.4
-46.03%-1.0631
-0.3084
Diluted earnings per share
-7.89%-0.41
-28.57%-0.45
5.00%-0.38
-39.22%-1.48
-19.97%-0.37
-16.84%-0.38
-41.01%-0.35
-120.73%-0.4
-46.03%-1.0631
-0.3084
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 135.56%987K-14.97%778K-46.74%620K-21.88%2.76M-76.25%262K-63.97%419K128.18%915K34.41%1.16M551.79%3.53M1.1M
Operating revenue 135.56%987K-14.97%778K-46.74%620K-21.88%2.76M-76.25%262K-63.97%419K128.18%915K34.41%1.16M551.79%3.53M--1.1M
Cost of revenue 65.85%68K-18.52%44K-22.73%34K-11.85%186K-11.32%47K-26.79%41K-10.00%54K4.76%44K6.03%211K53K
Gross profit 143.12%919K-14.75%734K-47.68%586K-22.52%2.57M-79.52%215K-65.85%378K152.49%861K35.92%1.12M438.63%3.32M1.05M
Operating expense 15.83%17.26M27.33%17.59M18.51%15.01M50.31%54.08M16.71%12.7M33.36%14.9M73.25%13.82M112.79%12.67M72.83%35.98M10.88M
Selling and administrative expenses -10.69%5.67M21.61%6.47M33.69%5.9M44.35%20.26M25.49%4.19M20.27%6.34M80.52%5.32M78.01%4.41M77.02%14.03M--3.34M
Research and development costs 35.49%11.6M30.91%11.13M10.39%9.11M54.12%33.82M12.83%8.51M45.08%8.56M69.00%8.5M137.59%8.25M70.25%21.95M--7.54M
Operating profit -12.52%-16.34M-30.13%-16.86M-24.93%-14.42M-57.72%-51.51M-26.99%-12.48M-44.27%-14.52M-69.71%-12.96M-125.14%-11.55M-49.81%-32.66M-9.83M
Net non-operating interest income expense 0.11%916K-4.14%902K14.80%1.02M7,598.00%3.85M136.25%1.11M1,352.38%915K482.52%941K475.00%885K105.39%50K469K
Non-operating interest income 0.11%916K-4.14%902K14.80%1.02M7,598.00%3.85M--1.11M--915K--941K--885K--50K----
Other net income (expense) 25.81%-23K80.00%-56K-46.15%-1.46M-269.57%-1.45M205.40%293K-193.94%-31K23.29%-280K-247.57%-1M-391K
Gain on sale of security ----25.81%-23K83.93%-45K2.19%-312K24.81%-294K205.40%293K-104.34%-31K23.29%-280K-10.76%-319K---391K
Special income (charges) -------------68.77%-1.15M-------------------682K--0
-Less:Other special charges ------------68.77%1.15M------------------682K--0
Other non- operating income (expenses) -----------11K----------------------------
Income before tax -15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M
Income tax
Net income -15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M
Net income continuous Operations -15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M---9.75M
Minority interest income
Net income attributable to the parent company -15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.85%-15.43M-32.66%-15.98M-23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M
Basic earnings per share -7.89%-0.41-28.57%-0.455.00%-0.38-39.22%-1.48-19.97%-0.37-16.84%-0.38-41.01%-0.35-120.73%-0.4-46.03%-1.0631-0.3084
Diluted earnings per share -7.89%-0.41-28.57%-0.455.00%-0.38-39.22%-1.48-19.97%-0.37-16.84%-0.38-41.01%-0.35-120.73%-0.4-46.03%-1.0631-0.3084
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data